Table 1.
Site2 alanine scan of hGH to the hGHR ECD2
kon (M−1 s−1, ×105) | koff (s−1, ×10−4) | Kda (nM) | Kd(Ala)/Kd(wt) | |
wt-hGH | 2.0 | 7.6 | 3.8 | 1 |
F1A-hGH | 0.77 | 25.6 | 33 | 9 |
P2A-hGH | 1.2 | 22.4 | 19 | 5 |
I4A-hGH | 3.3 | 295 | 89 | 23 |
P5A-hGH | 1.1 | 19.8 | 18 | 5 |
L6A-hGH | 2.3 | 13.8 | 6.0 | 2 |
R8A-hGH | 1.4 | 32.8 | 23 | 6 |
N12A-hGH | 2.8 | 7.4 | 2.6 | 0.7 |
L15A-hGH | 1.2 | 22.1 | 18 | 5 |
R16A-hGH | 2.0 | 96.1 | 48 | 13 |
R19A-hGH | 1.6 | 20.3 | 13 | 3 |
V102A-hGH | 1.8 | 19.6 | 11 | 3 |
Y103A-hGH | 2.2 | 18.6 | 8.5 | 2 |
N109A-hGH | 1.7 | 120 | 71 | 19 |
D116A-hGH | 2.0 | 6.2 | 3.1 | 0.8 |
E119A-hGH | 2.6 | 25.5 | 9.8 | 3 |
L6A,N12A-hGH | 3.0 | 8.1 | 2.7 | 0.71 (1)b |
L6A,D116A-hGH | 1.9 | 240 | 126 | 33 (2) |
N12A,D116A-hGH | 2.2 | 290 | 132 | 35 (0.6) |
R16A,D116A-hGH | 2.6 | 170 | 65 | 17 (11) |
R19A,D116A-hGH | 2.5 | 270 | 108 | 28 (2) |
Y103A,D116A-hGH | 3.6 | 110 | 31 | 8 (1) |
N109A,D116A-hGH | 2.2 | 45.4 | 21 | 6 (13) |
E119A,D116A-hGH | 2.0 | 253 | 127 | 33 (4) |
L6A,N12A,D116A-hGH | 1.9 | 510 | 268 | 71 (1) |
D116N-hGH | 2.6 | 33.4 | 13 | 3.68 |
D116V-hGH | 2.5 | 23.0 | 9.2 | 2.68 |
L6A,D116V-hGH | 1.5 | 220 | 147 | 39 (4) |
N12A,D116V-hGH | 3.1 | 220 | 71 | 19 (1) |
R16A,D116V-hGH | 2.0 | 67.3 | 34 | 9 (26) |
R19A,D116V-hGH | 2.0 | 237 | 119 | 31 (6) |
Y103A,D116V-hGH | 1.9 | 143 | 75 | 20 (4) |
N109A,D116V-hGH | 1.7 | 65 | 38 | 10 (38) |
E119A,D116V-hGH | 1.1 | 160 | 145 | 38 (6) |
Experiments were done in 10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM EDTA, 0.005% TWEEN-20 at 25°C.
a Equilibrium dissociation constant: Kd = koff/kon.
b Values in parentheses are the calculated binding additivities based on the single point mutations: [Kd(Ala1)/Kd(wt)] × [Kd(Ala2)/Kd(wt)].